Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?
- DOI
- 10.1016/j.euroneuro.2022.02.004
- Published
- 2022 Apr
- Container
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euroneuro.2022.02.004,
title = {Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?},
author = {Lengvenyte A and Strumila R and Olié E and Courtet P},
year = {2022},
journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
doi = {10.1016/j.euroneuro.2022.02.004},
url = {https://doi.org/10.1016/j.euroneuro.2022.02.004}
}RIS
TY - JOUR TI - Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how? AU - Lengvenyte A AU - Strumila R AU - Olié E AU - Courtet P PY - 2022 JO - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology DO - 10.1016/j.euroneuro.2022.02.004 UR - https://doi.org/10.1016/j.euroneuro.2022.02.004 ER -
APA
A, L., R, S., E, O., & P, C. (2022). Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2022.02.004
Source records
- pubmed · retrieved 2026-09-26T05:30:38.204Z